Neurogene (NGNE) Depreciation & Amortization (CF) (2013 - 2026)

Neurogene (NGNE) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $800000.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 6.81% year-over-year to $800000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (changed 0.19% YoY) and the FY2025 annual result came in at $3.0 million, down 6.25% from the prior year.
• Depreciation & Amortization (CF) climbed to $800000.0 in Q1 2026, from $733000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.0 million in Q4 2022 to a low of $323000.0 in Q3 2022.
• A 5-year average of $798352.9 and a median of $800000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 414.62% — and 2023, when it tumbled 55.16%.
• Tracing NGNE's Depreciation & Amortization (CF) over 5 years: stood at $2.0 million in 2022, then plunged by 55.16% to $900000.0 in 2023, then declined by 12.22% to $790000.0 in 2024, then slipped by 7.22% to $733000.0 in 2025, then gained by 9.14% to $800000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $800000.0 (Q1 2026), $733000.0 (Q4 2025), and $800000.0 (Q3 2025), per Business Quant data.